Caricamento...
Gefitinib for advanced non‐small cell lung cancer
BACKGROUND: The role of gefitinib for the treatment of advanced non‐small cell lung cancer (NSCLC) is evolving. We undertook a systematic review to evaluate the available evidence from all randomised trials. OBJECTIVES: To determine the effectiveness and safety of gefitinib as first‐line, second‐lin...
Salvato in:
| Pubblicato in: | Cochrane Database Syst Rev |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley & Sons, Ltd
2018
|
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6491254/ https://ncbi.nlm.nih.gov/pubmed/29336009 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD006847.pub2 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|